Atlas Trials

A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants

Clinical trial NCT03580824 · COMPLETED

Trial details

NCT number
NCT03580824
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malaria,Falciparum
Start date
2019-04-30
Primary completion
2022-06-14
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.